Recruiting OBSERVATIONAL NCT05275075

Identify microRNAs in Cachexia in Pancreatic Carcinoma (SCC-miRPanCa)

Pilot Trial to Identify microRNAs in Cachexia in Patients With Pancreatic Carcinoma

Sponsor: University of Oklahoma

Conditions Resectable Pancreatic Adenocarcinoma

Interventions Pancreatic cancer microRNA and messenger RNA expression.

Updated 9 times since 2022 Last updated: Jan 6, 2026 Started: Dec 7, 2022 Primary completion: May 1, 2026 Completion: May 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Resectable Pancreatic Adenocarcinoma, this trial is actively recruiting participants. The trial is conducted by University of Oklahoma and has accumulated 9 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Mar 2025 — Feb 2026 [monthly]

Recruiting
Sep 2024 — Mar 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 4 earlier versions

Nov 2023 — Mar 2024 [monthly]

Recruiting
Feb 2023 — Nov 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Feb 2023 [monthly]

Not Yet Recruiting
Apr 2022 — Sep 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oklahoma

Data source: University of Oklahoma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oklahoma City, United States